Royce & Associates’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Royce & Associates’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-38,400	Closed	-$184K	–	976
2022 Q3	$184K	Hold	38,400	–	–	﹤0.01%	889
2022 Q2	$99K	Hold	38,400	–	–	﹤0.01%	921
2022 Q1	$221K	Hold	38,400	–	–	﹤0.01%	938
2021 Q4	$576K	Hold	38,400	–	–	﹤0.01%	872
2021 Q3	$1.01M	Hold	38,400	–	–	0.01%	817
2021 Q2	$1.92M	Hold	38,400	–	–	0.01%	763
2021 Q1	$1.77M	Hold	38,400	–	–	0.01%	769
2020 Q4	$1.65M	Hold	38,400	–	–	0.01%	759
2020 Q3	$1.57M	Hold	38,400	–	–	0.02%	722
2020 Q2	$2.1M	Hold	38,400	–	–	0.02%	658
2020 Q1	$2.01M	Sell	38,400 -167,564	-81%	-$9.07M	0.03%	590
2019 Q4	$10M	Sell	205,964 -144,600	-41%	-$6.77M	0.09%	320
2019 Q3	$19.3M	Buy	350,564 +23,164	+7%	+$1.33M	0.18%	151
2019 Q2	$16.3M	Buy	327,400 +262,000	+401%	+$13M	0.15%	182
2019 Q1	$3.69M	Hold	65,400	–	–	0.03%	576
2018 Q4	$4.17M	Buy	65,400 +17,900	+38%	+$1.27M	0.04%	550
2018 Q3	$3.86M	Sell	47,500 -2,500	-5%	-$183K	0.03%	662
2018 Q2	$3.19M	Hold	50,000	–	–	0.02%	718
2018 Q1	$1.94M	Hold	50,000	–	–	0.01%	863
2017 Q4	$1.4M	Buy	+50,000	New	+$1.46M	0.01%	912

Other funds holding TRHC

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royce & Associates's TRHC Position: Q4 2022 in Review

Royce & Associates sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2022, closing a stake of 38,400 shares — an estimated $184K sold.

Royce & Associates first reported a position in TRHC in Q4 2017 and held it in 20 quarters. The position peaked at $19.3M in Q3 2019. 67 funds tracked by Wall St. Rank hold TRHC as of Q4 2022.

Royce & Associates reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Royce & Associates sold 38,400 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2022, an estimated $184K.
Royce & Associates first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
Royce & Associates's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $19.3M in Q3 2019.
67 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2022.

Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.